[HTML][HTML] Stem cells in clinical practice: applications and warnings

D Lodi, T Iannitti, B Palmieri - Journal of Experimental & Clinical Cancer …, 2011 - Springer
Stem cells are a relevant source of information about cellular differentiation, molecular
processes and tissue homeostasis, but also one of the most putative biological tools to treat …

Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide

S Brode, A Cooke - Critical Reviews™ in Immunology, 2008 - dl.begellhouse.com
Cyclophosphamide (CTX) is an alkylating cytotoxic drug that primarily affects proliferating
lymphocytes. CTX has been extensively used as a chemotherapeutic and disease-modifying …

[HTML][HTML] Advances in vitiligo: Update on therapeutic targets

Y Feng, Y Lu - Frontiers in immunology, 2022 - frontiersin.org
Vitiligo, whose treatment remains a serious concern and challenge, is an autoimmune skin
disease characterized by patches of depigmentation. The increasing application of …

Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy

R Sakthiswary, E Suresh - Lupus, 2014 - journals.sagepub.com
Objective The objective of this review is to evaluate the evidence for efficacy of methotrexate
(MTX) in systemic lupus erythematosus (SLE). Methods A comprehensive, computerized …

Environment and systemic lupus erythematosus: an overview

P Sarzi-Puttini, F Atzeni, L Iaccarino, A Doria - Autoimmunity, 2005 - Taylor & Francis
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology that
manifests as a pleomorphic systemic disease mainly affecting females. The variety of …

High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus

BJ Parker, IN Bruce - Lupus, 2007 - journals.sagepub.com
The pharmacological armamentarium for the treatment of SLE is expanding and a number of
novel therapies are currently under investigation. In spite of this, steroid therapy remains the …

Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion

R Perricone, C De Carolis, B Kröegler, E Greco… - …, 2008 - academic.oup.com
Objectives. We aimed to test the maternal and fetal outcome of SLE patients who suffered
from recurrent spontaneous abortion (RSA) treated with intravenous immunoglobulin (IVIg) …

Role of omega-3 fatty acid supplementation in inflammation and malignancy

DH Jho, SM Cole, EM Lee… - Integrative cancer …, 2004 - journals.sagepub.com
Omega-3 fatty acids (FAs), which include eicosapentaenoic acid (EPA) and
docosahexaenoic acid, are found in fish oils and have long been investigated as …

Effective self-management interventions for patients with lupus: potential impact of peer mentoring

EM Williams, L Egede, T Faith, J Oates - The American journal of the …, 2017 - Elsevier
Systemic lupus erythematosus (SLE) is associated with significant mortality, morbidity and
cost for the individual patient and society. In the United States, African Americans (AAs) have …

'Concealing the evidence': the importance of appearance concerns for patients with systemic lupus erythematosus

ED Hale, GJ Treharne, Y Norton, AC Lyons… - Lupus, 2006 - journals.sagepub.com
Outwardly visible signs associated with systemic lupus erythematosus (SLE) can include
facial rashes, alopecia and weight gain. We sought to understand the concerns of SLE …